PHARMACY: Jurnal Farmasi Indonesia p-ISSN 1693-3591

(Pharmaceutical Journal of Indonesia) e-ISSN 2579-910X

Vol.14 No. 01 Juli 2017

TITLE OF THE PAPER IN BAHASA INDONESIA (CALIBRI, 11PT, BOLD, UPPERCASE,

CENTERED)

TITLE OF THE PAPER (CALIBRI, 11PT, BOLD, UPPERCASE, CENTERED)

First Author’s name1,2, Second Author’s name2

1
Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University,
Jl. Sekip Utara, Sleman, Yogyakarta 55281, Indonesia
2
Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Jl. Raya Dukuhwaluh,
Dukuhwaluh, Kembaran, Purwokerto 53182, Indonesia
Email: xxxxx@gmail.com Author’s name)

ABSTRAK

Abstrak is written in Bahasa Indonesia. Author names must be given in full, with
surnames (family names). Where names may be ambiguous (e.g., a double name, or
possible confusion about first/last names), please indicate this clearly. Present the
authors' affiliation addresses (where the actual work was done) below the names.
Indicate all affiliations with a lowercase superscript number immediately after the
author's name and in front of the appropriate address. Author addresses must be given
in English in the following order: Department, Faculty, University, City, Country, with
numbers in superscript after each author name to indicate his/her address. Provide the
full postal address of each affiliation, including the country name for each author.

Kata kunci: kata kunci 1, kata kunci 2, kata kunci 3 (please enlist 4-8 kata kunci).

ABSTRACT

A concise and factual abstract, which is unstructured, is required. The abstract is limited
to 250 words or less for research and review articles and, 200 words or less for
commentaries. The abstract should state briefly the purpose of the research,
experimental approach, the principal results and major conclusions. An abstract is often
presented separately from the article, so the text should be comprehensible when read
alone. For this reason, references should be avoided. The use of numbers in the abstract
identifying compounds, formulas, tables or references and non-standard or uncommon
abbreviations should be avoided. However, if essential, they must be defined at their first
mention in the abstract. Each submission must be accompanied by a minimum of four to
a eight keywords that reflect the scientific content of your manuscript for subject
indexing at the end of the abstract. The keywords should be listed in full without
abbreviations. Be sparing with abbreviations: only abbreviations firmly established in the
field may be eligible.

Key words: key word 1, key word 2, key word 3 (please list 4-8 keywords).

1
PHARMACY: Jurnal Farmasi Indonesia p-ISSN 1693-3591
(Pharmaceutical Journal of Indonesia) e-ISSN 2579-910X
Vol.14 No. 01 Juli 2017

Pendahuluan (Introduction) between 10 to 15 printed pages. The

In this section, the authors
should state the objectives of the work,
define the scope of your
summarize relevant work to the study
being reported and provide an adequate
background. Paper should be written
concept base, theoretical, experimental
and empirical. A detailed literature
survey or a summary of the results
should be avoided. It should not be a
review of the subject area, but should
finish with a clear statement of the
question being addressed.
introduction must be designed to inform
full paper should be on A4 paper size.
The full article needs to be 1.5
spacing. The font size should be Calibri,
paper,
11pt. Ensure that each new paragraph is
clearly indicated.
Materials and Methods (Metode
Penelitian)
Heading has the following
characteristics: Boldface, Capitalize
each word. Leave 1.5 spacing before
beginning a new head. Divide your Full
Paper into clearly defined sections. Each
heading should appear on its own
The separate line. The title of each section
or subsection should be bold.

the reader of the rationale and

Sub-heading
significance of the study.
Sub-heading has the following
All registered submitted papers
characteristics: Flush Left, Italic
will be blind peer reviewed. Please
write your paper in good Capitalize Each Word.
English/Bahasa Indonesia. The length
of the full paper should preferably be

initial mass of PGV -0 -mass of precipitate

PGV  0 solubility  (1)
volume of vehicle)

Results and Discussions (Hasil dan Sub-heading has the following

Pembahasan characteristics: Flush Left, Italic
Sub-heading Capitalize Each Word.
Results should be clear and
concise. Text, tables and figures must

2
PHARMACY: Jurnal Farmasi Indonesia
(Pharmaceutical Journal of Indonesia)
Vol.14 No. 01 Juli 2017
show minimal overlap, and must be
internally consistent. Tables and figures
should be designed to maximize the
presentation and comprehension of the
experimental data. Attention should be
paid to the matter of significant figures
(usually, no more than three). The same
data should not be presented in more
than one figure or in both a figure and a
table.
The Results and Discussion
sections should be combined. Avoid
extensive citations and discussion of
published literature. The purpose of the
discussion is to interpret significance of
the results and to relate them to existing
knowledge in the field in as clear and
brief a fashion as possible. Information
given elsewhere in the manuscript
should not be repeated in the discussion.
Extensive reviews of the literature
should be avoided.
Please submit tables as editable
text and not as images. Tables should
not be placed next to the relevant text in
the article. They should be given on
separate page(s) after the references.
Number tables consecutively
accordance with their appearance in the
text and place any table footnotes below
the table body. Table headings should be
p-ISSN 1693-3591
e-ISSN 2579-910X
given above the table and written in
sentence case. Be sparing in the use of
tables and ensure that the data
presented in them do not duplicate
results described elsewhere in the article.
Please avoid using vertical rules.
All artworks, figures, images,
illustrations, graphics, photos, pictures,
plots and schemes should be labeled as
Figures. Figures should not be placed
next to the relevant text in the article.
They should be given on separate page(s)
after the references. All tables and
figures must have a caption and/or
legend and be numbered (e.g., Table 1,
Figure 2), unless there is only one table
or figure, in which case it should be
labelled “Table” or “Figure” with no
numbering. The font used in the figures
should be Calibri, 11pt.
All tables and figures must be
numbered consecutively as they are
referred to in the text. Please refer to
tables and figures with capitalisation and
unabbreviated (e.g., “As shown in Figure
2…”, and not “Fig. 2” or “figure 2”).
To ensure the highest print quality, your
in figures should be submitted in either
TIFF or JPEG format at the highest
possible resolution (300 dpi or higher).
3
 PHARMACY: Jurnal Farmasi Indonesia p-ISSN 1693-3591
(Pharmaceutical Journal of Indonesia) e-ISSN 2579-910X
Vol.14 No. 01 Juli 2017

Figure 1. Spectrum of PGV-0 in methanol.

Table 1. Precision and accuracy of the PGV-0 in methanol (n=3)

Concentration Accuracy (% recovery) Standard Deviation Precision (% RSD)

(ppm) Within-day Inter-day Within-day Inter-day Within-day Inter-day
2.00 98.81 99.81 0.03 0.04 1.75 1.88
5.00 98.66 98.32 0.06 0.09 1.29 1.93
7.00 98.71 100.74 0.10 0.12 1.44 1.68

Conclusion Avoid using references in conclusion

The main conclusions of the section.
study should be presented in a short
Conclusions section, which stands alone. References
You should explain whether your The example for reference from thesis
findings supported your hypothesis. (Skripsi/tesis/disertasi)

4
PHARMACY: Jurnal Farmasi Indonesia
(Pharmaceutical Journal of Indonesia)
Vol.14 No. 01 Juli 2017
Irianto, I.D.K. 2013. Formulasi
nanopartikel pentagamavunon-0
menggunakan kitosan viskositas
rendah dan natrium alginat
dengan metode gelasi ionik serta
uji antiinflamasi secara in vivo.
Thesis. Yogyakarta: Gadjah Mada
University.
The example for reference from book
Kazakevich, Y. and Lobrutto, R. Editors.
2007. HPLC for Pharmaceutical
Scientist. USA: John Wiley & Sons
Inc, New Jersey.
p-ISSN 1693-3591
e-ISSN 2579-910X
Snyder, L.R., Kirkland, J.J., and Dolan, J.W.
Editors. 2010. Introduction to
Modern Liquid Chromatography.
Third edition. New Jersey USA:
John Wiley & Sons, Inc.
The example for reference from journal
Patel, J., Kevin, G., Patel, A., Raval, M.,
and Sheth, N. 2012. Design and
development of a self-
nanoemulsifying drug delivery
system for telmisartan for oral
drug delivery. International
Journal of Pharmaceutical
Investigation, 1:112-118.